ERBB2 and breast cancer: In this study, we collected clinical and imaging data and final pathological findings from all 10 HER2-negative patients to evaluate the efficacy and safety of diagnostic ultrasound combined with contrast agent microbubbles and chemotherapy agents in patients with breast cancer.